Blog

Bain-backed startup strikes $500M deal with Eli Lilly

jeb-keiper900xx3494-2329-3-0

A month after detailing its strategic shift toward autoimmune diseases and cancer, Nimbus Therapeutics has captured the interest of a major pharmaceutical player.

Read More